fda stopping compounded semaglutide Compound versions of GLP-1 drugs for weight loss halted by altRx GLP-1 Review 2026: Updated

Key Takeaways BCBS coverage for Zepbound varies by state and plan type: There is no single BCBS policy each state affiliate and employer group sets its own formulary Prior authorization is almost always required: Even plans that cover Zepbound require clinical documentation before approving claims BMI thresholds typically apply: Most BCBS plans require a BMI 30, or 27 with a weight-related comorbidity like type 2 diabetes or hypertension Some BCBS affiliates have dropped GLP-1 coverage entirely: BCBS Michigan removed all GLP-1 weight loss drugs from fully insured commercial plans starting January 2025 Research-grade tirzepatide exists for laboratory use: Not a substitute for prescription medication, but available at significantly lower cost for research applications Zepbound (tirzepatide) launched in late 2023 as Eli Lilly's dedicated weight management version of Mounjaro

Similar to GH, IGF-1 alone stimulates the IRS1/Akt (Costoya et al., 2016)

Licensed medical professionals provide comprehensive care, including your initial visit, coaching provided by your weight loss team and ongoing medical check-ins from the comfort of your home

Ready to Start Your Peptide Therapy Journey

Cell 31 , 4860 (2014)

Month 4 and Beyond: Depending on your results and how you feel, your provider might move you to 1.7 mg or eventually a maximum maintenance dose of 2.4 mg